Basic Information
SerImmune is a developer of an immune intelligence platform designed to decode human immune responses and advance the development of diagnostics, vaccines, and treatments. The company's machine learning-based platform utilizes bacterial display peptide libraries, sequencing, and customized bioinformatics to map diverse antibodies in the library to antigens associated with infections, allergens, the microbiome, autoimmune diseases, and cancer, enabling healthcare practitioners to combat infectious and autoimmune diseases.
SerImmune
California,United States of America
less than 15 people
January 01, 2014
Info@serimmune.com
